Diphenhydramine hydrochloride; naproxen sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for diphenhydramine hydrochloride; naproxen sodium and what is the scope of patent protection?
Diphenhydramine hydrochloride; naproxen sodium
is the generic ingredient in two branded drugs marketed by Bayer Hlthcare, Amneal Pharms Co, Corepharma, Granules, P And L, and Perrigo R And D, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.Twenty-three suppliers are listed for this compound.
Summary for diphenhydramine hydrochloride; naproxen sodium
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 6 |
Finished Product Suppliers / Packagers: | 23 |
Clinical Trials: | 9 |
DailyMed Link: | diphenhydramine hydrochloride; naproxen sodium at DailyMed |
Recent Clinical Trials for diphenhydramine hydrochloride; naproxen sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ciusss de L'Est de l'Île de Montréal | N/A |
Alphacait, LLC | Phase 2 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
See all diphenhydramine hydrochloride; naproxen sodium clinical trials